share_log

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Moomoo 24/7 ·  Apr 1 16:08

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8.904 million by 2.54 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment